Ethanol Sclerotherapy for Postoperative Seroma of the Breast and Axilla
Journal of Breast Imaging · 2023
DOI: 10.1093/jbi/wbad001 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Breast Imaging, 2023. Verfasst von Camron B Smith und 4 weiteren Autor:innen. Beteiligte Einrichtung: University of Kansas Medical Center, Department of Radiology, Kansas City, KS, USA. Hauptthemen laut MEDLINE: Seroma, Breast Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 37 Literaturangaben.
Abstract (Originalsprache)
Objective
Evaluate the effectiveness of alcohol sclerotherapy in postoperative breast and axillary seromas.
Methods
This was an IRB-approved retrospective review of consecutive patients from 2017 to 2021. The procedure involves aspiration of seroma fluid, injection of ethanol for 15 to 30 minutes, and then aspiration of the injected ethanol. Following review of the medical record, patient and procedure data were recorded. Success was defined as no recurrence of seroma. Statistical analysis was performed using a chi-square or t-test, as appropriate.
Results
Twenty seromas were treated in 19 patients (mean age, 63 years; range, 49–79) following mastectomy (9/20, 45%), lumpectomy (25%, 5/20), axillary nodal dissection (5/20, 25%), or chest wall surgery (1/20, 5%). The mean seroma volume was 146 ± 165 mL. There was a mean of 1.4 prior aspiration attempts (range, 0–3). Mean injected ethanol volume was 39 mL (range, 8–60 mL) for a mean of 26 ± 5 minutes. Seromas recurred in 85% (17/20) of cases, and repeat aspiration was performed in 35% (6/17). The mean recurrence time was 34 ± 29 days. The recurrent seromas were 31% smaller (mean, 80 ± 48 mL). Only a smaller pre-ablation seroma was associated with successful ablation (P < 0.01), as the mean pre-ablation volume was 36 ± 24 mL for successful ablations and 119 ± 56 mL for unsuccessful ablations. There were no post-procedural complications.
Conclusion
Single-treatment ethanol sclerotherapy is typically unsuccessful in ablating breast and axillary seromas. Only a smaller pre-ablation seroma size was associated with successful ablation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- University of Kansas Medical Center, Department of Radiology, Kansas City, KS, USA.
- Duke University Hospital, Department of Radiology, Durham, NC, USA.
ORCID-Profile: Sora C Yoon, Lars Grimm
Zitieren
APA
Smith, C. B., Baker, J. A., Yoon, S. C., Lowell, D. A., & Grimm, L. (2023). Ethanol Sclerotherapy for Postoperative Seroma of the Breast and Axilla. Journal of Breast Imaging. https://doi.org/10.1093/jbi/wbad001
Vancouver
Smith CB, Baker JA, Yoon SC, Lowell DA, Grimm L. Ethanol Sclerotherapy for Postoperative Seroma of the Breast and Axilla. Journal of Breast Imaging. 2023. doi:10.1093/jbi/wbad001
BibTeX
@article{Smith2023,
author = {Smith, Camron B and Baker, Jay A and Yoon, Sora C and Lowell, Dorothy A and Grimm, Lars},
title = {Ethanol Sclerotherapy for Postoperative Seroma of the Breast and Axilla},
journal = {Journal of Breast Imaging},
year = {2023},
doi = {10.1093/jbi/wbad001}
}
EUVIMED